Leo is a placement student at the Epigenomics group. With the internship, he is completing his Master’s degree in Fundamental Neuroscience at Maastricht University, the Netherlands. He grew up in Erlangen, Germany, and went to Innsbruck, Austria, for his undergraduate in Molecular Medicine. In Innsbruck, he discovered his passion for Neuroscience, while working on a CRISPR-Cas9 construct to knock-down transcripts involved in memory formation. Within his time in Maastricht he worked on DNA methylation data to investigate possible biomarker for the progression of Alzheimer’s disease. Here in Exeter he will explore the epigenetic changes during differentiation and ageing of IPSC-derived neurons under the supervision of Katie Lunnon. By using different compounds to induce ageing, he wants to develop a human neuronal model for ageing-related diseases and neurodegenerative diseases.
Yaseen is a third year BSc Medical Sciences (Pharmacology and Therapeutics) student at the University of Exeter. He started his Professional Training Year (PTY) with the Complex Disease Epigenetics Group under the supervision of Asami Oguro-Ando. His project involves “Investigating the biological pathways of JAKMIP1 using Integrative network analysis associated with 15q duplication syndrome”.
Ailsa completed her Masters degree in Biomedical Science in 2018 with research focused on comparing epitope regions of islet autoantigens recognized by antibodies in the sera of Type 1 diabetes patients and HLA-DR4/DQ8 transgenic mice. After her degree, she took on the role of a research technician with the Diabetes and Metabolism group at the University of Bristol before being awarded a PhD studentship at the University of Exeter in 2019. Ailsa’s PhD research-working under Professor Jon Mill- is focused on genomic regulation in the developing pancreas. Ailsa has been a passionate dancer throughout her life, having been involved in companies such as the National Youth Ballet, as well as taking teaching roles at university.
Tom is a PhD student based at the University of Exeter, supervised by Dr Sarah Flanagan and Dr Emma Dempster. He graduated from the University of Exeter in the summer of 2019 with a BSc in Medical Sciences (Human Genomics). During his undergraduate degree, he completed a summer placement within the epigenetics lab at the RILD, where he shadowed Sam Washer in his work investigating functional epigenomics and schizophrenia. His dissertation focussed on the use of whole genome sequencing data to uncover novel causes of congenital hyperinsulinism with Dr Thomas Laver. His PhD project is to investigate the role of DNA methylation in congenital disorders of insulin secretion, based on Level 3 of the RILD with Dr Flanagan’s group.
Marcelo is an Austrian third year BSc Medical Sciences (Genomics) student at the University of Exeter. He is currently completing a Professional Training Year (PTY), and will work half the year in Tokyo’s National Cancer Centre with Dr Ryoichi Sadahiro. The second half of the year will be spent working with Exeter’s Complex Disease Epigenetics Group assisting Dr Jonathan Mill. His research focuses on potential genetic and immunological biomarkers associated with the onset of delirium.
As part of his BSc in Biological Sciences at Bournemouth University, Lachlan conducted research into the genetic factors of type II diabetes, using Drosophila nephrocytes as a model for the human podocyte. In 2018 Lachlan completed an MSc degree in Biotechnology at the University of Essex after researching the relationships between smoking, age-related methylation and blood neutrophil-to-lymphocyte ratio. In the last year Lachlan has worked at Cambridge Epigenetix as a primary operator of the hydroxymethylcytosine-pulldown pipeline, contributing to the company’s aim of using 5-hydroxymethylcytosine signatures found in cfDNA as a diagnostic tool. Under the supervision of Professor Katie Lunnon, Lachlan is now undergoing a PhD project studying the molecular changes resulting from amyloid-beta immunisation in Alzheimer’s disease through integrated systems-level analyses.
Aisha completed her undergraduate degree in Biomedical Sciences at the University of Birmingham. She focused on cell communication, with her research project specialising in understanding the genetic and protein changes in loss of Y chromosome in head and neck cancer. Staying on at Birmingham, she took a Msc in Bioinformatics where she analysed different datasets in several omics field using machine learning approaches. Her main project focused on single-cell RNA-seq analysis of mature and immature beta cells of healthy mouse. Aisha is interested in using these skills to understand genetic and epigenetic changes in disease and healthy states.
Betsan is a third year BSc Medical Sciences (Genomics) student at the University of Exeter. She has recently started her Professional Training Year (PTY) where she will spend 5 months with the Complex Disease Epigenetics Group under the supervision of Professor Jonathan Mill. The second half of her PTY will be spent in Tokyo at the National Cancer Centre Japan assisting Dr Ryoichi Sadahiro’s research of postoperative delirium. Her research project is titled “Gene regulatory changes through surgery and postoperative delirium”.
Josh completed his BSc Biochemistry (Hons) at the University of Kent in 2016 and following graduation was employed as a Molecular Pathologist at Eli Lilly and Co. in Surrey. His role at Lilly involved histological analysis of pathological processes in neurodegenerative diseases. He is particularly interested in neurobiology, genetics and neurodegenerative disease, specifically synucleinopathies. This led Josh to join the Complex Disease Epigenetics Group as a PhD student, with a project investigating epigenetic changes in the brains of Dementia with Lewy Bodies (DLB) and Parkinsons Disease Dementia (PDD) donors. He will be working under the supervision of Professor Katie Lunnon, Dr. Ehsan Pishva and Professor Jonathan Mill and the project is funded by The Charles Wolfson Charitable Trust.